Reuters Health News

Go to page:

Prev    1  2  3  4  5  6  7  8  9  10    Next

61. Outbreak of dengue fever hits island of Madeira
    Friday, October 12, 2012
    LONDON (Reuters) - Eighteen people are confirmed to be suffering from dengue fever in the Portuguese archipelago of Madeira and another 191 probably have the mosquito-borne disease, which is also called "breakbone fever" because of the severe pain it can cause.
62. Drug shortage led to spike in kids' infections
    Thursday, October 11, 2012
    NEW YORK (Reuters Health) - When there was a shortage of a drug used to prevent IV-related infections in kids, the frequency of those infections increased almost ten-fold at one Michigan hospital, a new study shows.
63. Questionable data propped up cancer drug Provenge
    Thursday, October 11, 2012
    NEW YORK (Reuters) - In Dendreon Corp's most important clinical trial for the controversial cancer therapy Provenge, researchers analyzed some of the data differently from how the company told U.S. regulators they would, according to documents reviewed by Reuters.
64. Therapy, exercise aid in chemo-related menopause
    Thursday, October 11, 2012
    NEW YORK (Reuters Health) - Younger women who are thrust into menopause because of breast cancer treatment may get some relief from talk therapy and regular exercise, a new study from the Netherlands suggests.
65. Doctors torn over heart screening for young athletes
    Thursday, October 11, 2012
    NEW YORK (Reuters Health) - Christopher Storm was a high school freshman and track runner when doctors found an abnormality in his heart. Part of the muscle was thicker than it should have been, making it harder for it to send blood to the rest of his body.
66. No clear link between organic food, birth defect
    Thursday, October 11, 2012
    NEW YORK (Reuters Health) - Baby boys whose moms ate organic during pregnancy do not seem to have a lower risk of a birth defect of the penis, a new study finds.
67. GlaxoSmithKline to reveal more drug secrets
    Thursday, October 11, 2012
    LONDON (Reuters) - GlaxoSmithKline, criticized in the past for keeping important information about its medicines to itself, is to lift the lid on more of its drug secrets.
68. In meningitis scare, charges firm misled regulators
    Thursday, October 11, 2012
    NASHVILLE, Tennessee (Reuters) - The deadly meningitis outbreak that has claimed a dozen lives is prompting calls for increased oversight of the nation's custom-made pharmaceutical industry, amid charges that the company at the center of the scare may have misled U.S. regulators.
69. Drugmakers put Nobel discoveries to test
    Thursday, October 11, 2012
    CHICAGO/LONDON (Reuters) - For some scientists, winning a Nobel Prize marks the end of a long and successful career.
70. Eat chocolate, win the Nobel Prize?
    Wednesday, October 10, 2012
    NEW YORK (Reuters Health) - Of all the chocolate research out there, the most unabashed tribute to the "dark gold" has to be a study just published in one of the world's most prestigious medical journals.
71. HIV death rates fall, but disparities remain: study
    Wednesday, October 10, 2012
    NEW YORK (Reuters Health) - New drug treatments have dramatically improved survival for people infected with HIV, but a new study finds that African Americans and less educated Americans have not seen the same gains as others, suggesting differences in access to available treatments.
72. Safety issues common after meds hit market in Canada
    Wednesday, October 10, 2012
    NEW YORK (Reuters Health) - Nearly a quarter of the new drugs approved in Canada eventually get a serious safety warning, or have to be pulled from the market for safety reasons, according to a new study.
73. CDC reports 18 more US cases in meningitis outbreak
    Wednesday, October 10, 2012
    (Reuters) - Eighteen more people have contracted meningitis from potentially tainted steroid injections, and a death was officially confirmed in Florida, bringing the total number killed to 12, the U.S. Centers for Disease Control said on Wednesday.
74. Study sees rise in young stroke sufferers
    Wednesday, October 10, 2012
    NEW YORK (Reuters Health) - Strokes are most common in old age, but new research suggests that lifestyle is putting young people increasingly at risk for stroke too.
75. Roche, Lilly drugs set for Alzheimer's prevention trial
    Wednesday, October 10, 2012
    NEW YORK (Reuters) - Experimental Alzheimer's drugs from Roche Holding AG and Eli Lilly & Co have been selected for a high-profile clinical trial to test whether it is possible to prevent the brain-wasting disease from ever developing in at-risk patients.

Go to page:

Prev    1  2  3  4  5  6  7  8  9  10    Next